Jul 2026
Targeting NRAS-Derived Public Neoantigens in T Cell-Based Cancer Immunotherapy 2261145
Biophysical, structural, and functional studies reveal how TCR promiscuity can be exploited to enhance scalability in neoantigen-targeting therapies.
Gihan Perera, Iñaki Etxeberria, C. Klebanoff et al.
· Journal of Immunology · 0 citations